Effects of intrathecal dexmedetomidine on intraoperative phantom limb syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-15007626

Enrollment

Unknown

Registered

2015-12-22

Start date

2016-02-22

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic surgery patients

Interventions

three groups:intrathecal dexmedetomidine

1:intrathecal morphine

2:Conventional intra-spinal canal anesthesia

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ASA I or II,25 to 60 and undergoing Combined spinal-epidural anesthesia in gynecological patients

Exclusion criteria

Exclusion criteria: Existence of intraspinal anesthesia contraindication, previous intraspinal anesthesia history, local anesthetic allergy, exist serious cardiovascular disease (such as bradycardia, conduction block, etc), Liver and kidney function serious insufficiency, mental disorders to cooperate.

Design outcomes

Primary

Measure	Time frame
anxiety, hunger, nausea, pain, thirst, tiredness;phantom limb syndrome;Duration of sensory blockade;Duration of motion blockade;Sensory block regression;Motor recovery time;Postoperative analgesic dosage;shiver;nausea and vomitting;	—

Countries

China

Contacts

Public ContactWenzhi Li

wenzhili9@126.com+86 18045159998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026